Close Menu

NEW YORK (GenomeWeb) – Phenomenex said this week that it is spinning off a new biological samples company, Neoteryx, focused on providing microsampling products that enable simpler, less invasive, and cost-effective methods of collecting and testing biological samples.

The new firm's main technology is its Volumetric Absorptive Microsampling (VAMS) technology. According to the company, the first product based on this technology – the Mitra Microsample Device – can collect 10 µL of fluid in seconds without volumetric blood hematocrit bias.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.